Polymorphous Low-grade Neuroepithelial Tumor of the Young: Case Report and Review Focus on the Radiological Features and Genetic Alterations
Overview
Affiliations
Background: A new type of epileptogenic tumor, the polymorphous low-grade neuroepithelial tumor of the young (PLNTY) was firstly reported by Jason T. Huse et al. at 2016. After that, only 1 case of PLNTY was reported by article. The radiological characteristics of PLNTY have not been concluded. The objective of our study was to report 3 cases of PLNTYs in details and to analyze the image characteristics and genetic alterations of PLNTYs by reviewing our cases and articles.
Case Presentation: There were 3 cases diagnosed as PLNTY by pathology in our hospital during the last 10 years, with the average age of 15. They were all suffered from different degrees of epilepsy. All of them underwent magnetic resonance (MR) imaging and 2 of them underwent computer tomography (CT) imaging. The PLNTYs are all appearing as a solid or solid-cystic cortical mass with little mass effect and unclear boundary with normal brain tissue. They are all shown as hyperintensity in T2WI and iso-/hypointensity in T1WI with slight or no enhancement after contract enhanced in MR imaging. The "salt and pepper sign" in T2WI and grit calcification in CT images might be specific characteristics of PLNTY. All of them recovered after excision of the tumors. The gene tests revealed fibroblast growth factor receptors 3 (FGFR3)-TACC3 fusion and FGFR3 amplification in one case, and the B-Raf proto-oncogene (BRAF) V600E mutation in another case.
Conclusion: In the image, the partial ill-marginated cortical mass with "salt and pepper sign" in T2WI or grit calcification in CT imaging might be the typical imaging characteristics of PLNTY. We also prove that the BRAF V600E mutation as well as the FGFR2 and FGFR3 have a close relationship with PLNTY.
Xu C, Beers C, Lu J, Hann C, Ramos R Front Neurol. 2024; 15:1482832.
PMID: 39582680 PMC: 11581895. DOI: 10.3389/fneur.2024.1482832.
Phenotypic and epigenetic heterogeneity in FGFR2-fused glial and glioneuronal tumours.
Metais A, Dangouloff-Ros V, Garcia J, Vannod-Michel Q, Csanyi M, Tauziede-Espariat A Neuropathol Appl Neurobiol. 2024; 50(6):e13014.
PMID: 39511841 PMC: 11618513. DOI: 10.1111/nan.13014.
Metabolism: an important player in glioma survival and development.
Wang N, Yuan Y, Hu T, Xu H, Piao H Discov Oncol. 2024; 15(1):577.
PMID: 39436434 PMC: 11496451. DOI: 10.1007/s12672-024-01402-5.
Cortically Based Brain Tumors in Children: A Decision-Tree Approach in the Radiology Reading Room.
Rameh V, Lobel U, DArco F, Bhatia A, Mankad K, Poussaint T AJNR Am J Neuroradiol. 2024; 46(1):11-23.
PMID: 39181692 PMC: 11735440. DOI: 10.3174/ajnr.A8477.
Rao S, Goyal A, Johnson A, Sadashiva N, Kulanthaivelu K, Vazhayil V Brain Tumor Pathol. 2024; 41(3-4):109-116.
PMID: 39154303 DOI: 10.1007/s10014-024-00487-8.